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The Adderall Epidemic: Linking Illicit Adderall Use to Mental Distress on College
Campuses
Abstract
Background
Psychostimulants are widely misused on college campuses for recreation and academic
gain, but many students are not aware of the impact of these drugs on mental health. Literature
proposes psychostimulant use decreases the availability of dopamine receptors, thus promoting
symptoms of mental distress. The purpose of this study is to assess the physical and mental
symptoms of misuse, identify the populations at risk of misusing psychostimulants, and to
deduce the most effective approaches to persuade users about the adverse effects of misuse.
Methods
An anonymous electronic survey was distributed to 596 college students in the
Northeastern United States assessing demographics, perception of safety, frequency of use and
mental health status. This survey was advertised on social media platforms, campus flyers, and
tabling events. Pearson’s Correlation Coefficient and Principal Component Analysis (PCA) were
used to analyze data in SPSS version 25.0.
Results
Misusing psychostimulants is significantly correlated with higher levels of mental
distress such as anxiety, depression, panic attacks, irritability, and suicidal thoughts. Risk factors
for psychostimulant misuse include Greek life affiliation, age, and GPA. Participants stated that
education via real life stories and mechanistic illustrations of negative physiological side effects
would dissuade future misuse of psychostimulants.
Conclusions
Our research agrees with the literature connecting psychostimulant misuse and mental
distress. This study provides insights to support informational sessions on college campuses to
diminish the abuse of ADHD medications by college students. Efforts should be directed to
educating the risky populations such as social science majors and Greek life organizations.
Keywords: Substance Use and Abuse, Mental Distress, GPA, Psychostimulants, Greek Life
Introduction
The non-prescription use of Attention-Deficit/Hyperactivity Disorder (ADHD)
psychostimulant medications such as Adderall, Ritalin, and Vyvanse is a prevalent and urgent
issue impacting college students, yet research on the issue is limited. Studies report a range of
17% to 43% of American college students have used ADHD medications for non-medicinal
purposes (Benson et al., 2015; DeSantis, Webb, and Norr, 2008).
Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD is a neurobehavioral disorder defined by symptoms of inattention and hyperactive
impulses (American Psychiatric Association, 2000). The condition typically commences during
childhood and about 50% of cases continue into adulthood (Wilens et al., 2004). Many of the
symptoms of the disorder are due to disrupted or dysregulated dopamine neurotransmission in
the central nervous system (Misener et al., 2004). Low levels of dopamine culminate in
decreased motivation from the reward system; this is why patients with ADHD struggle to
sustain attention on goal-oriented behaviors.
A dysfunctioning prefrontal cortex (PFC) also plays a key role in the cause of ADHD
symptoms (Spencer, et al. 2015). The PFC plays a key role in maintaining attention assigning
significance to the subject matter. The PFC also filters out distractions, shifting focus, and
organizing thoughts and behaviors to achieve goals. In addition, the PFC regulates hyperactivity
via the area’s ability to regulate inappropriate emotions, impulses, and behaviors. Genetic
linkage studies display that ADHD is associated with decreased dopamine release in the PFC
(Castellanos, 2001). Small changes in dopamine concentrations in the PFC can excite the
pyramidal cells and have marked effects on PFC function (Arnsten, 2009), disrupting the PFC’s
attention and hyperactivity regulation abilities. In patients with ADHD, neuroimaging displays
anatomical alterations which would effectively decrease dopaminergic function in dopamine-rich
portions of the brain like the PFC (and the striatum) (Castellanos, 2001).
Psychostimulant use for ADHD and Drug Mechanism
Along with behavioral therapy, a common and effective treatment for ADHD (as well as
other CNS conditions such as narcolepsy) is the prescription of medications such as Adderall®
(mixed salt amphetamine), Ritalin® (methylphenidate), Vyvanse® (lisdexamfetamine
dimesylate) and Dexedrine®(dextroamphetamine). These compounds increase monoamine
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neurotransmitter release in areas of the brain like the PFC and striatum, thus effectively treating
symptoms of inattentively and impulsivity prominent in cases of ADHD. The efficacy of these
medications for the use of treating ADHD have been confirmed (Gross, 1976; Greenhill et al.,
2003, Faraone et al., 2006).
The most commonly prescribed psychostimulant to treat ADHD is Adderall, which is
amphetamine-based. The chemical structure of amphetamines dictates its function. The planar
geometry, small molecular size, aromatic rings, and a Nitrogen on the aryl side chain are
structural qualities similar to that of neurotransmitter monoamines. These monoamines include
catecholamine neurotransmitters such as dopamine, serotonin, and noradrenaline (Holmes &
Rutledge, 1976). Due to its similar molecular structure to monoamines, amphetamines enter the
cell through dopamine transporters, and proceed to alter the function of monoamine transporters
like noradrenaline transporter (NET), dopamine transporter (DAT), and serotonin transporter
(SERT), as well as vesicular monoamine transporter 2 (VMAT2) to reverse transport
monoamines. The combined outcome is “reverse-transport:” reuptake transporters excessively
pump neurotransmitters from the presynaptic neuron cytoplasm and storage vesicles into the
synapse, rather than from the synapse back into the presynaptic neuron (Robertson et al., 2009).
The other most common drug used to treat ADHD is methylphenidate (Ritilan®).
Methylphenidate acts through a similar method compared to amphetamines of increasing
synapse concentrations of catecholamine neurotransmitters in the synapse. The drug contrasts
from amphetamines by blocking reuptake of the neurotransmitters, rather than causing efflux of
neurotransmitters. (Kuczenski & Segal, 2002). Regardless, the effect is similar to that of
amphetamines: an increase of neurotransmitters in the CNS.
The flooding of the CNS with these monoamines stimulates the catecholamine-deficient
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regions of the PFC and striatum in patients with ADHD. The result is increased attention, focus,
and decrease in impulsive behaviors. This same mechanism of neurotransmitter release causes
the feeling of euphoria and increased motivation in non-ADHD individuals. This “high”
encourages the recreational use of the psychostimulants and is one of the primary reasons for the
misuse of these medications.
Misuse of ADHD Medications
Today in the United States, the misuse of ADHD medications is on the rise in the college
student population. Students who misuse ADHD medications report doing so due to the increase
in attention and cognition they report to have while on the drug. Despite this perception, ADHD
medication use in non-ADHD individuals is negatively related with GPA (Begdache et al.,
2019). Additional evidence suggests that non-prescription use of ADHD drugs has no significant
effect on attention (Repantis et al., 2010). These medications may also inhibit cognitive abilities
such as cognitive flexibility and decision making (Smith & Farah, 2011). Conversely, other
studies found small to moderate increase in function of working-memory, delayed memory and
processing speed (response-time) in individuals who were administered small doses of
amphetamines (Ilieva et al., 2015). Possible proposed explanations for these improvements were
the placebo effect, or an increase in motivation (resulting from the release of dopamine upon
intake of amphetamines) (Weyandt et al., 2016).
Effects of Long-term Misuse
The US Drug Enforcement Agency (DEA) classifies ADHD medications as Schedule II
drugs due to their potential for addiction, dependency, and abuse. Other Schedule II drugs
include cocaine, pain medications such as opium and OxyContin, and Phencyclidine (PCP)
(United Stated Department of Justice, DEA, 2017). Despite the legal implications and potential,
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students continue to abuse these medications illicitly (without a prescription from a licensed
physician). As stated before, psychostimulants are widely considered safe for individuals to
consume when given the proper dosage, and even children are prescribed the medications at a
young age. The perceived safety of these medications has contributed to the normalization and
increase in prevalence of psychostimulant misuse on college campuses (DeSantis & Hein, 2009).
But the use of psychostimulants for recreation or academic benefit by individuals who do not
have ADHD can have long-term adverse effects.
Most of the long-term adverse effects stem from dopamine dysregulation. Ricaurte et. al
(2005) describes a decrease in striatal dopamine up to 30-50% in primates treated with doses of
Adderall mimicking those in human clinical treatment. Other research describes a
downregulation of dopamine receptor (D2/3) availability due to amphetamine-based
psychostimulants like Adderall (Schrantee, et al., 2017). Downregulation of dopamine receptors
is linked to anxiety, depression, nervousness, loss of motivation, and psychosis (Varga, 2012).
Amphetamine abusers also exhibit deficits in decision-making cognition, which is hypothesized
to be connected to the dysregulation of dopamine in the PFC (Rodgers, 1999). Given the delayed
development of the PFC, college students are particularly vulnerable to developing psychiatric
disorders related to PFC dysfunction (i.e. depression, anxiety, schizophrenia). Environmental
factors like illicit stimulant use has been evidenced to exacerbate these risks by dysregulating
dopamine in the developing brain (Paus, 2008).
In essence, many students who illicitly use non-prescription ADHD medications are
uninformed or misinformed about the physical and mental impacts of these medications. The
purpose of this study is to identify and classify patterns of physical and mental symptoms of
misuse, classify perceived safety of the drug, determine populations at risk of misusing Adderall,
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and to deduce the most effective approaches to persuade users about the adverse effects of
misuse.
Methods
The Institutional Review Board at Binghamton University Human Subjects Research
Review Committee reviewed and approved the study protocol. Inclusion criteria included being
18 years or older and being enrolled in a US college. The anonymous survey was built in Google
Forms and the link was sent through social media platforms requesting responses from US
college students. Participants gave consent to the study by accessing the survey. For Binghamton
University data collection, the survey was shared on social media and advertised at tabling
events on campus and no compensation was provided for participation. A total of 596 individuals
completed the survey. The latter included a total of 40 questions addressing demographics,
psychostimulant use, perceptions of psychostimulant safety, and potential methods to dissuade
psychostimulant use. Responses were on a 6 likert-scale. In this survey, psychostimulants were
first listed as “such as, but not limited to; Adderall, Ritalin, Concerta, or Vyvanse”. Data were
analyzed by employing Pearson’s Correlation Coefficient and a Principal Component Analysis
(PCA). The PCA was used to identify patterns in the data set that associate with the different
beliefs and patterns of behaviors within the data set, which are important to understanding the
reason behind misuse of psychostimulants. Sampling adequacy and inter-correlation of variables
were assessed using Kaiser-Meyer-Olkin (KMO) test and Bartlett’s test of sphericity,
respectively. To determine the number of principal components (PCs) retained, eigenvalue >1.0
criterion was used. A factor loading of 2.0 or more was considered. Additionally, the number of
PCs selected was confirmed by visually examining the screen plot. PCs were then orthogonally
rotated (varimax) to simplify and enhance their interpretability. All data were analyzed using
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SPSS version 25.0.
Results
Demographics
Participants (n=596) self-reported sex, age, Greek life affiliation, ethnicity, and location
of their college (Table 1).
Unprescribed psychostimulant use
Non-prescription psychostimulant misuse was positively correlated with social
fraternities/sororities affiliation, social science majors, economics majors, males, alcohol
consumption more than twice a week, recreational painkiller use, and low GPA. Hard science
majors and participants without Greek affiliation were negatively correlated with
non-prescription psychostimulant misuse.
Those who obtained unprescribed psychostimulants illegally were positively correlated
with receiving it from a fraternity or sorority member (p<0.05) and negatively correlated with
receiving it from a friend (p<0.05) (Table 2).
Side Effects
Those who used unprescribed psychostimulants reported panic attacks, weight loss,
inability to concentrate, anxiety, irritability, depression, fatigue, headache, aggression, paranoia,
lack of motivation, mood swings, sleep difficulty, and suicidal thoughts during use of
unprescribed psychostimulants (Table 3).
Perceived Safety
Principal Component Analysis (PCA) identified 2 components: (1) Perception of
psychostimulants safety and (2) Pattern for frequent users of psychostimulants. Component 1
reflects a pattern of perception that alcohol, marijuana, prescription painkillers, and caffeine as
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less safe than psychostimulants and that those individuals would not be dissuaded by the
negative psychological and psychological effects of psychostimulants. Component 2 reflects a
pattern of frequent psychostimulant users who believe that psychostimulant is equally as safe as
alcohol and prescription painkillers and that psychostimulants are safer than cocaine. Component
2 reveals that frequent psychostimulant users are stressed at least once a week and negative
psychological and physiological effects would not be a strong enough motivator to dissuade use
of psychostimulant.
Education
As for the educational outreach approaches, survey participants stated that sharing real
life stories (38.9%) and negative side effects (35.9%) would be likely to dissuade their personal
unprescribed psychostimulant use.
Discussion
The purpose of this study was to assess the relationship between psychostimulant use and
overall mental health of college students. Particularly, this study focused on the adverse mental
health effects potentially caused by unprescribed use of psychostimulants. The main findings of
this study are: 1) Psychostimulants highly correlate with reports of adverse side effects and 2)
Specific subpopulations of students including psychology majors and Greek affiliated students
are more likely to misuse psychostimulants. The effects of prescription stimulants on mental
wellbeing have been fairly well documented from a pharmacological perspective. Due to
fluctuations in monoamine regulation, individuals who take psychostimulants regularly often
report feelings of depression and anxiety (Sherzada, 2011). To evaluate mental health,
participants were asked to report all adverse effects experienced from both prescribed and
unprescribed use of psychostimulants. In accordance with the literature, our results did reveal a
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number of adverse side effects with regard to mental health of the user. Ailments such as panic
attacks, aggression, paranoia, weight loss, irritability, anxiety, suicidal thoughts, and lack of
motivation all strongly correlated with psychostimulant use. Along with the current literature,
these findings are extremely concerning when we consider the breadth of psychostimulant use
across college campuses.
A secondary aim of the present study was to identify subpopulations of college students
most at risk for this epidemic as well as general perceptions of psychostimulant use. The major
findings from our survey suggest that students in social science majors such as psychology and
economics are most likely to be using non-prescription psychostimulants. Before assuming that
psychology and economics majors are the most at risk, however, it is important to test group
difference between majors. In addition to use risk with respect to major, data showed that the
most at-risk groups of users reside within the Greek life community. Our results revealed that
there was a prominent correlation between non-prescription psychostimulant use and
membership in a fraternity or sorority. Out of those users belonging to the aforementioned
demographic, many reported acquiring the medication from another member of their fraternity or
sorority. These findings align with McCabe et al. (2004) who described that Adderall use was
correlated with membership in a social fraternity/sorority. Despite support from literature in the
field, it is important to consider the impacts of selection bias on this survey.
Another concerning finding was the degree to which individuals use other drugs in
addition to the non-prescription psychostimulant use. Drinking alcohol more than twice a week
as well as recreational painkiller use correlates with non-prescription psychostimulant use. It is
possible that psychostimulant abuse may prime the brain for further substance use, hence,
individuals using these medications are more likely to use other drugs and engage in risky
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behavior (Jardin et al., 2011).
A major contributing factor to the epidemic of non-prescription psychostimulant use
potentially revolves around the perceived safety of these types of drugs by college students. Our
data shows that a significant number of participants reported perceiving psychostimulants as
safer to use than prescription painkillers. In fact, the data suggests that many college students are
not aware nor educated about the risks associated with non-prescription psychostimulant use.
This notion of perceived safety largely ties into the Health Belief Model created in the 1950s
(Rosenstock et al., 1988). The Health Belief Model hypothesizes that health-related action is
largely reliant on three factors: 1) Sufficient motivation to make a particular issue relevant, 2)
The belief that one truly is vulnerable to a particular health threat, and 3) The belief that
following a particular recommendation would be beneficial in preventing illness. With regard to
perceived safety, it is imperative to consider point (2) of the Health Belief Model. To elaborate,
it is very likely that college students who are not educated about psychostimulants do not
perceive themselves to be vulnerable to the negative side effects of these drugs. As a result, some
students may have the inherent belief that they are immune to the negative consequences of
psychostimulants misuse. To combat this, it is imperative to reallocate university budgets in
order to create programming that informs students about not only alcohol and marijuana, but also
the dangers of psychostimulant misuse. When asked about prevention measures, participants
reported that education via real life stories and illustrations of adverse side effects would be most
likely to dissuade use. With regard to point (3) of the Health Belief Model, these findings suggest
that true stories of the dangers of Adderall and similar drugs may encourage college students to
be more open to listening to recommendations from health professionals. By implementing these
measures in seminars and other information sessions, abuse of psychostimulants by college
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students may be reduced. Our data suggest that it is imperative to specifically target at risk
groups such as social science majors and Greek life organizations.
Conclusion
In summary, the current study reports that college students who illicitly used
psychostimulants experienced symptoms of mental distress, such as depression, anxiety, and
panic attacks. These findings are of great importance because hundreds of college students abuse
psychostimulants yearly without knowledge of the implications. Without a proper education
concerning psychostimulants, these students risk damaging their mental and physical health in a
futile effort to excel in academics via medication misuse. Despite these efforts to boost academic
performance, data revealed a negative relationship between illicit
psychostimulant use and GPA. Additionally, mental distress, which may be caused by
substance misuse is linked to lower academic performance. This conclusion along with other
findings support the need for educational interventions to dissuade at risk students from illicit
psychostimulant use.
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Table 1. Showing demographic breakdowns of survey participants. N=596. * denotes p<0.05.
**denotes p<0.01
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Table 2. Showing correlation values for unprescribed psychostimulant use with various
demographics. N=596. * denotes p<0.05. **denotes p<0.01
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Table 3. Showing correlation values for unprescribed psychostimulant use with symptoms.
N=596. * denotes p<0.05. **denotes p<0.01
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Table 4. Principal Component Analysis (PCA) with varimax rotation. Principal components
loading for A) perception of psychostimulant safety, B) frequency of psychostimulant use
patterns.
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